Use of gaba agonists for treatment of spastic disorders,...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/13 (2006.01) A61K 31/00 (2006.01) A61K 31/16 (2006.01) A61K 31/165 (2006.01) A61K 31/195 (2006.01) A61M 5/142 (2006.01)

Patent

CA 2378955

According to the subject invention, there is disclosed a method for treating a patient/subject having a spastic disorder, a convulsive disorder, pain or epilepsy which includes administering to the subject having any one of these conditions a therapeutically effective amount of the compound gamma- aminobutyramide, analogs, substituted forms, derivatives, the pharmaceutically acceptable salts, esters, amides, and prodrugs thereof, or compounds which yield gamma-aminobutyramide as an intermediate, a metabolite, or a by-product.

L'invention concerne un procédé permettant de traiter un patient/sujet souffrant de troubles spastiques et convulsifs, de douleurs ou d'épilepsie, qui consiste notamment à lui administrer une dose efficace du composé gamma-aminobutyramide, d'analogues, de formes substituées, de dérivés, des sels pharmaceutiquement acceptables, d'esters, d'amides et de promédicaments de ceux-ci, ou des composés qui produisent gamma-aminobutyramide comme intermédiaire, métabolite ou sous-produit.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of gaba agonists for treatment of spastic disorders,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of gaba agonists for treatment of spastic disorders,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of gaba agonists for treatment of spastic disorders,... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1887152

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.